Vasopressors & The Older Patient - The 65 Trial

April 27, 2020 00:22:04
Vasopressors & The Older Patient - The 65 Trial
Critical Care Perspectives in Emergency Medicine
Vasopressors & The Older Patient - The 65 Trial

Apr 27 2020 | 00:22:04

/

Show Notes

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic HTN. Recent literature, however, suggests increased mortality in older patients who are exposed to larger quantities of vasopressor medications.  In this podcast, we do a deep dive into the recently published 65 Trial, which sought to evaluate the effect of permissive hypotension in older patients with vasodilatory hypotension.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

September 25, 2018 00:24:02
Episode Cover

PARAMEDIC2 - Is Epi Useful in OHCA?

Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA.  PARAMEDIC2 was just published and is the largest randomized...

Listen

Episode 0

May 25, 2017 00:21:05
Episode Cover

Euglycemic DKA

We discuss the case of a young patient presenting with euglycemic DKA.  Say what?  How common is this entity and what is the impact...

Listen

Episode

April 15, 2025 00:25:31
Episode Cover

When Should We Start Vasopressin in Septic Shock?

Sepsis results in more than 250,000 deaths each year in the United States. Resuscitation of the septic patient centers on timely recognition, early antibiotic...

Listen